The U.S. Food and Drug Administration (FDA) and drug manufacturer Novo Nordisk are warning consumers about “counterfeit” ...

Accordingly, neither Novo Nordisk ... needles cannot be confirmed, which presents an increased risk of infection for patients who use counterfeit products. Based on analyses completed to date ...

The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...

The FDA and drugmaker Novo Nordisk ... needles, which means the FDA could not certify that the needles are sterile and not a risk of infection. Patients should double-check their Ozempic ...

A federal court judge ruling leaves in place an FDA determination that shortages of the Novo Nordisk drugs Wegovy and Ozempic ...

In his suit, Todd Engel, of Howard County, accused Novo Nordisk Inc. and 10 other companies involved with the manufacturing, marketing and distribution of Ozempic, of failing to disclose the ...

Novo Nordisk, the maker of Ozempic, prices each pen at $997.58, regardless of strength — ranging from 0.25 to 2 milligrams (mg). The total cost of Ozempic can vary depending on the dosage ...